Blog Archives - Page 71 of 77 - NFCR

Blog

Highlights of ASCO 2017

Founded in 1964, the American Society of Clinical Oncology (ASCO®) is the world’s leading professional organization for physicians and oncology professionals caring for people with cancer. Each year, tens of thousands of oncology professionals, cancer researchers and patient advocates gather at The ASCO Annual Meeting  to discuss the latest in…...

Read more

Simple, Sensational Cancer-Fighting Salsa

Snacking on salsa is a simple and tasty way to add cancer-fighting fruits and veggies to your diet.  With a variety of ingredients from tomatoes, jalapenos or habanero peppers to mangoes, pineapples, strawberries and even beans, salsa can spice up meal-time. Salsa is not just a savory dip for chips…...

Read more

2017 Szent-Györgyi Prize for Progress in Cancer Research Awarded to Michael N. Hall

More than 170 guests enjoyed a fabulous Monday evening at the National Press Club recognizing Michael N. Hall, Ph.D., Professor of Biochemistry at the Biozentrum of the University of Basel in Switzerland, as the 2017 recipient of the Szent-Györgyi Prize for Progress in Cancer Research presented by the National Foundation…...

Read more

8 Facts You Need to Know About Skin Cancer

May is National Skin Cancer Prevention and Detection Month and Melanoma Awareness Month. As skin cancer is the most common type of cancer in the U.S. and the most treatable, when caught early, it’s important to understand what you can do to protect yourself. Background: Each year there are more…...

Read more

Improving the Delivery and Efficacy of Anti-Cancer Therapeutics

In honor of National Medical Laboratory Professional Week, we’d like to highlight a few of the many accomplishments of NFCR-funded scientist, Dr. Rakesh Jain. About Dr. Rakesh Jain Rakesh K. Jain, Ph.D., Andrew Werk Cook professor of tumor biology (radiation oncology) at Harvard Medical School and director of the Edwin…...

Read more

Understanding Adaptive Clinical Trials

Testing new treatments is key to successfully treating cancer. Unfortunately, the current model for conducting clinical trials — evaluating the effectiveness of therapies on human subjects — is inefficient, expensive and suffers from high failure rates. To overcome these challenges, the practice of adaptive trials is emerging and has become one…...

Read more

The Pioneering Gene Work of Dr. Mary-Claire King

The Szent-Györgyi Prize was established in honor of Nobel laureate Dr. Albert Szent-Györgyi, co-founder of NFCR, to recognize outstanding scientific achievement in the war against cancer. Ten years later, “ASG Winners: Then & Now” looks at these winners, their extraordinary contributions and how their discoveries have made possible new approaches…...

Read more

NFCR’s Genomics Newsroom: New genes linked to increased risk of ovarian and brain cancer

What is “genomics”? Cancer develops when genetic material (DNA) becomes damaged or changed. We know some cancer causing genetic changes are acquired (i.e. smoking), while others are inherited. Studying cancer genomics explores the differences between cancer cells and normal cells. Advances in understanding how cancer behaves at a genomic and…...

Read more